Guangzhou Baiyunshan Pharmaceutical Holdings

company

About

Guangzhou Baiyunshan Pharmaceutical Holdings manufactures and sells Chinese patent medicine.

  • 10001 - max

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$1.43M
Industries
Manufacturing,Medical,Pharmaceutical
Founded date
Jan 1, 1997
Number Of Employee
10001 - max
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.43M
Guangzhou Baiyunshan Pharmaceutical Holdings has raised a total of $1.43M in funding over 2 rounds. Their latest funding was raised on Feb 23, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 23, 2022 Post-IPO Equity $1.43M 1 Source Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Guangzhou Baiyunshan Pharmaceutical Holdings is funded by 1 investors. Source Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Source Capital Yes Post-IPO Equity